SCHEMBL609836

SCHEMBL609836

FC(F)(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc21

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.60
TP53 P04637 2/20 0.60
ALOX15 P16050 2/20 0.60
MAPK1 P28482 2/20 0.60
CYP3A4 P08684 1/20 0.60
BAX Q07812 2/20 0.57
SIGMAR1 Q99720 1/20 0.40
NCF1 P14598 1/20 0.39
RAD52 P43351 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HTT P42858 1/20 0.36
TRPV4 Q9HBA0 1/20 0.36
PER2 O15055 1/20 0.36
CRY1 Q16526 1/20 0.35
CRY2 Q49AN0 1/20 0.35
DNM1 Q05193 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5024609 0.80 MAPT (0.41) MAPTTP53ALOX15MAPK1CYP3A4
Hydrochloric Acid SCHEMBL31038642 0.77 MAPT (0.73) MAPTTP53ALOX15MAPK1CYP3A4
Hydrochloric Acid SCHEMBL29462932 0.77 MAPT (0.73) MAPTTP53ALOX15MAPK1CYP3A4
SCHEMBL20704845 0.76 BAX (0.61) MAPTTP53ALOX15MAPK1CYP3A4
SCHEMBL29992291 0.76 BAX (0.72) MAPTTP53ALOX15MAPK1CYP3A4
SCHEMBL5024320 0.76 BAX (0.72) MAPTTP53ALOX15MAPK1CYP3A4
SCHEMBL607745 0.76 BAX (0.72) MAPTTP53ALOX15MAPK1CYP3A4
SCHEMBL29398838 0.76 BAX (0.72) MAPTTP53ALOX15MAPK1CYP3A4
SCHEMBL5024339 0.76 BAX (0.72) MAPTTP53ALOX15MAPK1CYP3A4
Hydrochloric Acid SCHEMBL31457408 0.75 MAPT (1.00) MAPTTP53ALOX15MAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP claimed
EP-1237887-A1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2002-09-11 EP claimed
WO-2001029028-A1 9- (PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-26 WO claimed
US-8410110-B2 9-(piperazinylalkyl) carbazoles as Bax-modulators MERCK SERONO SA (CH) 2013-04-02 US disclosed
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2012-02-16 US disclosed
US-8053436-B1 9-(piperazinylalkyl) carbazoles as bax-modulators MERCK SERONO SA (CH) 2011-11-08 US disclosed
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP disclosed
EP-1237887-A1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2002-09-11 EP disclosed
WO-2001029028-A1 9- (PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS BCL2, BAX, BAD MAPT 1085/4885TP53 1113/4885ALOX15 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.